12 Most Promising Future Stocks According to Wall Street Analysts

Page 9 of 11

3. Revolution Medicines, Inc. (NASDAQ:RVMD)

Analyst Upside: 97.53%

Number of Hedge Fund Holders: 61

Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the most promising future stocks according to Wall Street analysts. On August 18, Piper Sandler initiated coverage of Revolution Medicines, Inc. (NASDAQ:RVMD) with an Overweight rating and a $75 price target.

Revolution Medicines, Inc. (NASDAQ:RVMD) reported its fiscal Q2 2025 results on August 6, reporting strong execution of two ongoing Phase 3 trials of daraxonrasib.

Management reported that the company is winding down enrollment in the US for RASolute 302 and anticipates the completion of the enrollment of the trial this year.

Revolution Medicines, Inc. (NASDAQ:RVMD) also reported that the FDA Breakthrough Therapy Designations were granted for two RAS(ON) inhibitors, daraxonrasib and elironrasib.

Revolution Medicines, Inc. (NASDAQ:RVMD) is a clinical-stage precision oncology company that develops novel targeted therapies. It discovers and develops cancer treatments through novel combination and monotherapy treatment regimens that enhance clinical benefits.

Page 9 of 11